Research archive

Charles P. Theuer, M.D., Ph.D.

Charles P. Theuer, M.D., Ph.D., Director at 4D Molecular Therapeutics, Inc.. Biography, career history and compensation sourced from SEC proxy filings.

About

Director since December 2015. Chief Medical Officer at Halozyme since October 2024; former President and CEO of Tracon Pharmaceuticals (2006-2024).

Roles

4D Molecular Therapeutics, Inc.

Director · Current role

2015–present

Director Compensation

FY 2025

Fees earned or paid in cash

$65,000

Option awards

$70,000

Total

$135,000

Also at 4D Molecular Therapeutics, Inc.

David Kirn, M.D.

Co-Founder, President, Chief Executive Officer and Director

John F. Milligan, Ph.D.

Director and Executive Chairman

Jacob Chacko, M.D., MBA

Related

4D Molecular Therapeutics, Inc.

See how Top Bucket AI works for your firm

Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.

Dated reference snapshot as of September 10, 2026. This is not a live financial feed. Verify figures against primary filings before relying on them.